Aquatic Capital Management LLC Uro Gen Pharma Ltd. Transaction History
Aquatic Capital Management LLC
- $3.86 Billion
- Q1 2025
A detailed history of Aquatic Capital Management LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 3,627 shares of URGN stock, worth $30,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,627
Previous 9,446
61.6%
Holding current value
$30,067
Previous $100,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding URGN
# of Institutions
142Shares Held
41.6MCall Options Held
91.4KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$36.1 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$31.8 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$26.6 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$19.1 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$18.2 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $189M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...